Personalised anti-inflammatory therapy for bronchiectasis and cystic fibrosis: selecting patients for controlled trials of neutrophil elastase inhibition

BACKGROUND: Neutrophil elastase (NE) has been linked to lung neutrophil dysfunction in bronchiectasis and cystic fibrosis (CF), making NE inhibition a potential therapeutic target. NE inhibitor trials have given mixed result perhaps because not all patients have elevated airway NE activity. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Keir, Holly R., Fong, Christopher J., Crichton, Megan L., Barth, Philip, Chevalier, Eric, Brady, Gill, Kennedy, Gwen, Zimmermann, Johann, Bruijnzeel, Piet L.B., Dicker, Alison J., Chalmers, James D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6431753/
https://www.ncbi.nlm.nih.gov/pubmed/30918898
http://dx.doi.org/10.1183/23120541.00252-2018

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6431753/
https://www.ncbi.nlm.nih.gov/pubmed/30918898
http://dx.doi.org/10.1183/23120541.00252-2018

Ejemplares similares